Press release
Global Antibody-drug Conjugates Sales Market Trends, Price, Revenue, Share, Growth and Forecast From 2017-2022
Market_Research_Hub
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1303110
Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Antibody-drug Conjugates for these regions, from 2012 to 2022 (forecast), covering:
United States
China
Europe
Japan
Southeast Asia
India
Global Antibody-drug Conjugates market competition by top manufacturers/players, with Antibody-drug Conjugates sales volume, Price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including:
F. Hoffmann-La Roche
Seattle Genetics
Takeda Pharmaceuticals
AbbVie
AbGenomics
ADC Therapeutics
Agensys
ALMAC Group
Ambrx
Astellas Pharma
On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into:
Seattle Genetics technology
ImmunoGen technology
Immunomedics technology
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody-drug Conjugates for each application, including:
IgG1 antibodies
HER2 antibodies
Browse Full Report with TOC @ http://www.marketresearchhub.com/report/global-antibody-drug-conjugates-sales-market-report-2017-report.html
Table of Content:
Global Antibody-drug Conjugates Sales Market Report 2017
1 Antibody-drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugates
1.2 Classification of Antibody-drug Conjugates by Product Category
1.2.1 Global Antibody-drug Conjugates Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Antibody-drug Conjugates Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Seattle Genetics technology
1.2.4 ImmunoGen technology
1.2.5 Immunomedics technology
1.3 Global Antibody-drug Conjugates Market by Application/End Users
1.3.1 Global Antibody-drug Conjugates Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 IgG1 antibodies
1.3.3 HER2 antibodies
1.4 Global Antibody-drug Conjugates Market by Region
1.4.1 Global Antibody-drug Conjugates Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.3 China Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.4 Europe Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.5 Japan Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.6 Southeast Asia Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.7 India Antibody-drug Conjugates Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Antibody-drug Conjugates (2012-2022)
1.5.1 Global Antibody-drug Conjugates Sales and Growth Rate (2012-2022)
1.5.2 Global Antibody-drug Conjugates Revenue and Growth Rate (2012-2022)
2 Global Antibody-drug Conjugates Competition by Players/Suppliers, Type and Application
2.1 Global Antibody-drug Conjugates Market Competition by Players/Suppliers
2.1.1 Global Antibody-drug Conjugates Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Antibody-drug Conjugates Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Antibody-drug Conjugates (Volume and Value) by Type
2.2.1 Global Antibody-drug Conjugates Sales and Market Share by Type (2012-2017)
2.2.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2012-2017)
2.3 Global Antibody-drug Conjugates (Volume and Value) by Region
2.3.1 Global Antibody-drug Conjugates Sales and Market Share by Region (2012-2017)
2.3.2 Global Antibody-drug Conjugates Revenue and Market Share by Region (2012-2017)
2.4 Global Antibody-drug Conjugates (Volume) by Application
….continue
Make an Enquiry @ http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1303110
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients and customers.
Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Antibody-drug Conjugates Sales Market Trends, Price, Revenue, Share, Growth and Forecast From 2017-2022 here
News-ID: 681535 • Views: …
More Releases from Market Research Hub - Pharmaceutical Industry
Global Enthesopathy Treatment Market Analysis by Type, Application, Top Key Play …
The global market status for Enthesopathy Treatment is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Enthesopathy Treatment Market Size, Status and Forecast 2019-2025”, which tends to deliver in-depth knowledge associated to the Enthesopathy Treatment market for the present and forecasted period until 2025. Furthermore, the report examines the target market based on market size,…
Global BioImaging Technologies Market Status, Growth Opportunity, Scope, Key Pla …
The market for BioImaging Technologies is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global BioImaging Technologies Market Size, Status and Forecast 2019-2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore,…
Global Drugs and Diagnostics for Hematological Disorders Market Report Overview …
Market Research Hub (MRH) has actively included a new research study titled “Global Drugs and Diagnostics for Hematological Disorders Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period…
Global Biosimilar Testing and Development Services Market Report Overview 2019-2 …
Market Research Hub (MRH) has actively included a new research study titled “Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until…
More Releases for Conjugates
Global Cancer Antibody Drug Conjugates Market
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions:
• Global Cancer Antibody Drug Conjugates Market: 2020 - 2030
• Global Cancer Antibody Drug Conjugates Market Opportunity > US$ 50 Billion By 2030
• Approved Cancer Antibody Drug Conjugates: 16 Drugs
• Approved Cancer Antibody Drug Conjugates Sales Insights, Patent, Dosage and Price Analysis
• Cancer Antibody Drug Conjugates In Clinical Trials: > 500 Drugs
• Cancer Antibody Drug Conjugates Clinical…
Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,…
DLL3 Antibody-Drug Conjugates: Mechanisms and Efficacy
Antibody-drug conjugates (ADCs) represent a revolutionary approach in cancer treatment, combining the targeting capabilities of antibodies with the cytotoxic power of chemotherapy. DLL3 (Delta-Like Ligand 3) has emerged as a promising target for ADCs, particularly in the treatment of small cell lung cancer (SCLC) and other neuroendocrine tumors. This article explores the mechanisms and efficacy of DLL3 ADCs, shedding light on their potential in modern oncology.
Download Report:
https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor
DLL3 is a…
Radionuclide Drug Conjugates (RDC) Market Minimizing Side Effects, Maximizing Im …
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Oncology Antibody Drug Conjugates Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is projected to grow from USD 9.87 billion in 2022 to USD 22.48 billion at a CAGR value of 12.4% from 2022 to 2027.
Pfizer Inc., Astellas Pharma Inc., Gilead Sciences, Inc., GlaxoSmithKline, F. Hoffmann-La Roche AG, Daiichi Sankyo, AstraZeneca, Sanofi, AbbVie, Merck & Co., Byondis, RemeGen, ImmunoGen, Seagen, Rakuten Medical,…
Global Antibody Drug Conjugates Market Insights, Forecast
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement…
